- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
- Locations
-
- Octapharma Research Site St. Petersburg, Florida, United States
- Octapharma Research Site Columbus, Georgia, United States
- Octapharma Research Site Macon, Georgia, United States
- Octapharma Research Site New Orleans, Louisiana, United States
Clinical trial condition
Agammaglobulinemia
Explore clinical trials studying Agammaglobulinemia. Study availability and eligibility vary by location and protocol.
29 public trials
9 recruiting studies
Agammaglobulinemia trial results
NCT03961009
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
- Locations
-
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Rush University Medical Center Chicago, Illinois, United States
- Dr. Henry J. Kanarek - Allergy, Asthma & Immunology Overland Park, Kansas, United States
- Midwest Immunology Clinic and Infusion Center Plymouth, Minnesota, United States
NCT00161993
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Tampere University Hospital Tampere, Finland
- Turku University Central Hospital Turku, Finland
- SU/Sahlgrenska Gothenburg, Sweden
- University Hospital Lund Lund, Sweden
Completed
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
NCT01581593
- Conditions
- Agammaglobulinemia, Antibody Deficiency, Blood Protein Disorders, +11 more
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
- Rush University Chicago, Illinois, United States
NCT02508584
- Conditions
- Agammaglobulinemia, Arthritis, Arthritis, Infectious, +15 more
- Locations
-
- Brigham and Women's Hosptial Boston, Massachusetts, United States
NCT03401268
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +6 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT01002755
- Conditions
- Agammaglobulinemia, Blood Platelet Disorders, Blood Protein Disorders, +33 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00115778
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
- Locations
-
- New York Presbyterian Hospital Lung Transplant Program New York, United States
NCT02043379
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Abnormalities, +13 more
- Locations
-
- Children's of Alabama Birmingham, Alabama, United States
Completed
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
NCT00520494
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
- Locations
-
- Contact CSL Behring for facility details Edmonton, Alberta, Canada
- Contact CSL Behring for facility details Montreal, Quebec, Canada
- Contact CSL Behring for facility details Leipzig, Germany
- Contact CSL Behring for facility details Brescia, Italy